Cellectis (CLLS) EPS (Basic) Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.92% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -37.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.56% |
| Dec 31, 2025 | 33.89% |
| Sep 30, 2025 | 54.06% |
| Jun 30, 2025 | 462.85% |
| Mar 31, 2025 | 32.70% |
| Dec 31, 2024 | 62.22% |
| Sep 30, 2024 | 27.13% |
| Dec 31, 2023 | 9.44% |
| Sep 30, 2023 | -208.05% |
| Jun 30, 2023 | -155.91% |
| Mar 31, 2023 | -31.20% |
| Dec 31, 2022 | 58.81% |
| Sep 30, 2022 | 41.40% |
| Jun 30, 2022 | 90.85% |
| Mar 31, 2022 | 36.05% |
| Dec 31, 2021 | 36.39% |
| Sep 30, 2021 | -11.22% |
| Jun 30, 2021 | -17.45% |
| Mar 31, 2021 | 12.17% |
| Dec 31, 2020 | -5.85% |
| Sep 30, 2020 | 0.82% |
| Jun 30, 2020 | -2.56% |
| Mar 31, 2020 | 35.10% |
| Dec 31, 2019 | -19.39% |
| Sep 30, 2019 | -9.70% |
| Jun 30, 2019 | -30.84% |
| Mar 31, 2019 | 10.31% |
| Jun 30, 2018 | -4.30% |